GH Research Raises $125 Million to Fund DMT Treatment for Depression
GH Research closed a $125 million Series B financing round to fund the advancement of its 5-MeO-DMT treatment.
GH Research closed a $125 million Series B financing round to fund the advancement of its 5-MeO-DMT treatment.
The first conference of its kind, the Jewish Psychedelic Summit, will explore the connection between psychedelics and Judaism.
Toronto’s Silo Wellness is now trading on the German Stock Exchange as demand for psychedelic treatments expands.
In this week’s episode of The Spotlight Roundup, we check in with the Fireside Project, the first-ever 24/7 psychedelic peer support line; the State of Oregon forms an advisory board to oversee the implementation of psilocybin use in specialized clinics; and The American Journal of Psychiatry publishes new guidance on how to safety and effectively use Ketamine and Esketamine.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.